Shili Ni - Shandong Weigao Ex Director

SHWGFDelisted Stock  USD 0.96  0.00  0.00%   

Insider

Shili Ni is Ex Director of Shandong Weigao Group
Age 61
Phone86 63 1562 1999
Webhttps://www.weigaogroup.com

Shandong Weigao Management Efficiency

The company has return on total asset (ROA) of 0.0604 % which means that it generated a profit of $0.0604 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1276 %, meaning that it generated $0.1276 on every $100 dollars invested by stockholders. Shandong Weigao's management efficiency ratios could be used to measure how well Shandong Weigao manages its routine affairs as well as how well it operates its assets and liabilities.
Shandong Weigao Group has accumulated 3.46 B in total debt with debt to equity ratio (D/E) of 0.2, which may suggest the company is not taking enough advantage from borrowing. Shandong Weigao Group has a current ratio of 2.93, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Shandong Weigao until it has trouble settling it off, either with new capital or with free cash flow. So, Shandong Weigao's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Shandong Weigao Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Shandong to invest in growth at high rates of return. When we think about Shandong Weigao's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Andrew ChangCarl Zeiss Meditec
N/A
Euan ThomsonCarl Zeiss Meditec
60
Justin LeongResMed Inc
48
Dennis KaysenColoplast A
N/A
Vered KeisarResMed Inc
N/A
Steven MDCarl Zeiss Meditec
N/A
Augustine JDHoya Corp
55
Dorthe RonnauColoplast A
57
Molly JosephWest Pharmaceutical Services
46
Richard LuzziWest Pharmaceutical Services
72
Constance BienfaitResMed Inc
N/A
Rajwant SodhiResMed Inc
46
Marco CatalaniEssilorLuxottica Socit anonyme
N/A
Francis TanHaemonetics
N/A
Warner HThe Cooper Companies,
56
Mike WangCarl Zeiss Meditec
N/A
Mike WangCarl Zeiss Meditec
N/A
Robert SeguraWest Pharmaceutical Services
N/A
BE MBAResMed Inc
50
Gerard IIIThe Cooper Companies,
60
Steven MDCarl Zeiss Meditec
N/A
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the Peoples Republic of China. The company was incorporated in 2000 and is based in Weihai, the Peoples Republic of China. Shandong Weigao operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 11476 people. Shandong Weigao Group [SHWGF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Shandong Weigao Group Leadership Team

Elected by the shareholders, the Shandong Weigao's board of directors comprises two types of representatives: Shandong Weigao inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Weigao's management team and ensure that shareholders' interests are well served. Shandong Weigao's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Weigao's outside directors are responsible for providing unbiased perspectives on the board's policies.
Junqiang Lu, Ex Director
Shili Ni, Ex Director
Miu Wong, Company Secretary
Hong Ju, Vice-General Manager of the Production and Supply Chain
Rinan Cong, CEO Director
Xue Wu, Chief Officer
Jing Long, Vice-General Manager of Marketing Management

Shandong Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shandong Weigao a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in Shandong Pink Sheet

If you are still planning to invest in Shandong Weigao Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shandong Weigao's history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Managers
Screen money managers from public funds and ETFs managed around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities